Lv22
174 积分 2026-04-01 加入
Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody–Drug Conjugate for the Treatment of Solid Cancers
7天前
已完结
New payloads drive next-gen antibody–drug conjugates
11天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
22天前
已完结
A coiled-coil masking domain for selective activation of therapeutic antibodies
24天前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
1个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
1个月前
已完结
皖公网安备34019202002308
